OTTAWA, May 5, 2014 /CNW/ - Tweed Marijuana Inc. (TSXV: TWD) is pleased
to announce that its wholly owned subsidiary Tweed Inc. ("Tweed") has
shipped its first orders of medical marijuana to customers. The
product, which has been produced in Tweed's Smiths Falls facility from
"seed to sale", has been tested by Tweed to be in conformance with the
Health Canada Marihuana for Medical Purposes Regulations (MMPR).
"We are very happy that Tweed's medicine is en route to those who need
it," said Tweed CEO and Co-founder Chuck Rifici. "The team at Tweed is
committed to making more and more strains available as quickly as
Registered customers may now visit Tweed's online store to purchase
their medical marijuana.
About Tweed Marijuana Inc.
Tweed Marijuana Inc. (TSXV: TWD) is a TSX Venture Exchange listed
company. Its wholly owned subsidiary, Tweed, is a licensed producer of
medical marijuana in Canada. The principal activities of Tweed are the
production and sale of marijuana out of its facility in Smiths Falls,
Ontario as regulated by the Marihuana for Medical Purposes Regulations. To learn more about Tweed, visit www.tweed.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Tweed Marijuana Inc.
For further information:
Tweed Inc | (855) 558 9333